Dr. Ward is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1950 Circle of Hope
Clinic 3a
Salt Lake City, UT 84112Phone+1 801-585-0100Fax+1 801-587-8143
Education & Training
- University of Utah HealthFellowship, Hematology and Medical Oncology, 1979 - 1982
- Duke University HospitalResidency, Internal Medicine, 1976 - 1979
- Duke University HospitalInternship, Internal Medicine, 1976 - 1977
- University of Utah School of MedicineClass of 1976
Certifications & Licensure
- UT State Medical License 1979 - 2026
- WY State Medical License 2002 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Top MD Consumers Checkbook
Clinical Trials
- Study of GPX-100 in the Treatment of Metastatic Breast Cancer Start of enrollment: 2005 Mar 01
Publications & Presentations
PubMed
- 1 citationsTOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer.Christos Vaklavas, Cindy B Matsen, Zhengtao Chu, Kenneth M Boucher, Sandra D Scherer
JCO Precision Oncology. 2024-07-01 - 9 citationsProspective Pilot Study ofF-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas.Matthew F Covington, John M Hoffman, Kathryn A Morton, Brandon Buckway, Kenneth M Boucher
AJR. American Journal of Roentgenology. 2023-08-01 - 80 years of Clinical Hematology.George M Rodgers, John H Ward, Paul F Bray
British Journal of Haematology. 2022-09-01
Grant Support
- Clinical Trial: Study Of Tamoxifen And Raloxifene (STAR) For The Prevention Of BNational Center For Research Resources2008
- Study Of Tamoxifen And Raloxifene (STAR) For The Prevention Of Breast CancerNational Center For Research Resources2007
- Study For Prevention Of Breast CancerNational Center For Research Resources2004–2006
- Chemoprevention Trial (TAMOXIFEN) In Proliferative Breast DiseaseNational Center For Research Resources1997–1999
- National Surgical Adjuvant Breast And Bowel Project--Breast Cancer PreventionNational Center For Research Resources1997
- Genetic Analysis Of Breast CancerNational Center For Research Resources1997
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: